Procurement Summary
Country: Brazil
Summary: Acquisition of Medicines to Meet Administrative and Judicial Demands with and Without Trademark Determination
Deadline: 07 May 2026
Posting Date: 22 Apr 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 139951968
Document Ref. No.: 90226/2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Acquisition of Medicines to meet Administrative and Judicial Demands with and without Trademark Determination UASG code: 90201 Notice from: 04/22/2026 from 08:00 to 12:00 and from 13:00 to 17:59 Hs Proposal Delivery: from 04/22/2026 at 08:00 INSULIN, ASPART TYPE, COMPOSITION WITH NICOTINAMIDE (VIT B3), CONCENTRATION 100 IU/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 150 INSULIN, ASPART TYPE, COMPOSITION WITH NICOTINAMIDE (VIT B3), CONCENTRATION 100 IU/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 1272 INSULIN, ASPART TYPE, COMPOSITION WITH NICOTINAMIDE (VIT B3), CONCENTRATION 100 IU/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONS WITH APPLICATION SYSTEM Quantity: 24 INSULIN, ASPART TYPE, COMPOSITION WITH NICOTINAMIDE (VIT B3), CONCENTRATION 100 IU/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONS WITH APPLICATION SYSTEM Quantity: 513 INSULIN, DETEMIR ORIGIN, DOSAGE 100U/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONAL FEATURE WITH APPLICATION SYSTEM Quantity: 42 PALIPERIDONE, CONCENTRATION 9 MG, PHARMACEUTICAL FORM PROLONGED RELEASE Quantity: 180 PYRVINE, PAMOATE COMPOSITION, CONCENTRATION 10 MG/ML, PHARMACEUTICAL FORM ORAL SUSPENSION Quantity: 240 MEDICINAL EXTRACT, COMPOSITION PELARGONIUM SIDOIDES DC., CONCENTRATION 825 MG/ ML, PHARMACEUTICAL FORM ORAL SOLUTION Quantity: 30 PSYLLIUM HYDROPHILIC MUCILOID, PLANTAGO OVATA COMPOSITION, CONCENTRATION 492MG/G, PHARMACEUTICAL FORM POWDER FOR PREPARATION EXTEMPORARY Quantity: 6 PSYLLIUM HYDROPHILIC MUCILOID, COMPOSITION PLANTAGO OVATA, CONCENTRATION 562MG/G, PHARMACEUTICAL FORM POWDER FOR EXTEMPORARY PREPARATION Quantity: 527 RANOLAZINE, CONCENTRATION 500 MG, ADDITIONAL PROLONGED RELEASE Quantity: 360 RISANKIZUMAB, CONCENTRATION 150 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONAL CHARACTERISTICS WITH ...
Documents
Tender Notice